|
Contents
|
|
|
|
Brain
Tumors
|
|
|
|
Bai
F, Minkin P, Fraga CH, O'shaughnessy MA, Gururangan S, Stewart CF.
Determination of Cloretazine [trade mark (VNP40101M)] and its active
metabolite (VNP4090CE) in human plasma by liquid chromatography electrospray
tandem mass spectrometry (LC-ESI-MS/MS).
J
Chromatogr B Analyt Technol Biomed Life Sci. 2007 Mar 24; [Epub ahead
of print]
|
|
|
Gururangan S, Turner CD, Stewart CF,
O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R,
Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE
Phase I Trial of VNP40101M (Cloretazine) in Children with Recurrent Brain
Tumors: A Pediatric Brain Tumor Consortium Study
Clin
Cancer Res. 2008 Feb 15;14(4):1124-30
.JPG) Abstract
|
|
|
|
